Fresh analysis indicates that individuals who discontinue new slimming jabs like Mounjaro or Wegovy can put back on shed pounds at a significantly accelerated pace than those who end traditional lifestyle programs.
Published data in a prominent medical journal demonstrates that while overweight individuals frequently drop a large proportion of their body weight while undergoing treatment, the mass is regained at an estimated rate of nearly a kilo each month once they quit.
"Individuals purchasing these medications should be cognizant of the potential of quick rebound weight gain when the treatment ends," warns researcher Dr. Susan Jebb.
This pace of regain implies a return to starting weight within about one and a half years.
Analyzing Therapies
The study, which reviewed dozens of studies involving thousands of patients, contrasted the results of these new drugs with conventional dieting.
Scientists emphasize that individuals who lose weight through diet and exercise typically have a slower creep back—around 100 grams monthly—post-intervention.
The Reason for the Quick Rebound
Nutrition scientists propose the mode of action of the jabs explains the accelerated regain.
GLP-1 drugs mimic a natural hormone called GLP-1, which controls feelings of fullness.
"Long-term administration of the hormone concentrations far above than normal may cause the body to generate a reduced amount of its own natural hormone, and may also reduce sensitivity to its effects," explained Dr. Adam Collins, a nutrition expert.
"Discontinuation of this GLP-1 'fix' leads to hunger is unsuppressed, making overeating a significant risk."
A Chronic Condition?
Health authorities advise the jabs for people with obesity-related medical conditions, accompanied by recommended diet and exercise modifications.
Many experts contend that, given the high risk of relapse, the treatment might need to be long-term.
This opinion is echoed by pharmaceutical companies, who state that the findings "emphasize the chronic character of excess weight," akin to managing diseases like high blood pressure.
Patient Testimonies
Individuals who have stopped the jabs report a intense resurgence of hunger.
"I experienced something that goes on and you become extremely hungry," recalled an individual.
This difficulty is worsened if patients have not developed lasting dietary or behavioural changes during therapy.
Significant Adoption
Recent estimates indicate that a significant number of adults in the UK have tried weight-loss jabs in the past year, with interest being substantial.
- Adoption is higher among women compared to men.
- The middle-aged age group shows the highest level of interest.
- Many obtain the medications through private prescriptions rather than the NHS.
In conclusion, experts stress that while these medications are effective tools for shedding pounds, they are not a permanent cure and lasting health benefits relies on integrated lifestyle support.
